© 2022 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 22, 2019
Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results
March 27, 2019
Some patients are hesitant to use this class of drugs because of the stigma of potential addiction.
September 03, 2018
The number of individuals diagnosed with cancer steadily increases each year.
January 23, 2018
Cancer is the second-leading cause of death in the United States.